Stomach Cancer Clinical Trials

A listing of Stomach Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Arizona

UPDATED

Tucson Arizona 85715

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

California

UPDATED

La Jolla California 92037-0845

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Stanford California 94305

A clinical trial seeking patients for a research study for the treatment of Stomach Cancer, Gastric (Stomach) Cancer, Neoplasm of Cardioesophageal Junction or Gastrointestinal Stromal Tumor (GIST)

Oklahoma

UPDATED

Tulsa Oklahoma 74146

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Washington

MultiCare Health System
Tacoma Washington 98405

Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach

Argentina

UPDATED

Buenos Aires 1025

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Rosario 2000

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Viedma 8500

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Australia

UPDATED

Adelaide 5000

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

France

UPDATED

Brest 29609

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Creteil 94010

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Lyon 69437

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Paris 75013

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Hungary

UPDATED

Budapest 1125

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Kaposvar 7400

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Szolnok 5000

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Poland

UPDATED

Gdansk 80-219

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Lodz 90-242

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Poznan 61-485

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Warszawa 04-125

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Romania

UPDATED

Baia Mare 430031

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Cluj-Napoca 400058

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Craiova 200347

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Russian Federation

UPDATED

Arkhangelsk 163045

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Kursk 305035

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

St. Petersburg 194291

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Slovakia

UPDATED

Bratislava 833 10

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Kosice 041-90

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Germany

Berlin 13125

A clinical trial to evaluate treatments for patients with Colo-rectal Cancer, Stomach Cancer or Melanoma

Korea, Republic of

Busan 612-896

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Daegu 702-210

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Goyang-si, Gyeonggi-do 410-769

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Jeollanam-do 519-763

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seongnam-si, Gyeonggi-do

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

View More ▼

Seoul 120-752

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seoul 152-703

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seoul 137-701

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seoul 138-736

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seoul 135-720

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seoul 135-710

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Suwon 443-380

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer